NIH-funded research R01 grant

Using fecal bile acids to predict necrotizing enterocolitis in premature infants

Official title: Assessing Variation in Fecal Bile Acids as a Novel Early Indicator of Necrotizing Enterocolitis

Funded at University of Arizona · NIH-11049130 · Data updated 2026-11-12

This study is looking at how changes in bile acids in the poop of premature babies might help doctors spot necrotizing enterocolitis (NEC) early, so they can take action before any symptoms show up.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Arizona
NIH-funded
Lab location1 site (Tucson, United States)
Project startMarch 15, 2024
Project endJanuary 31, 2029
Funding year2025
Award (this year)$547,703
NIH project number5R01DK135567-02
Project IDNIH-11049130 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are premature infants admitted to neonatal intensive care units.

Less likely to help

Patients who are not premature or those who do not develop necrotizing enterocolitis may not benefit from this research.

What this research studies

This research investigates the role of fecal bile acids as potential early indicators of necrotizing enterocolitis (NEC) in premature infants. By collecting daily fecal samples from infants in neonatal intensive care units, the study aims to identify variations in bile acid levels that may predict the onset of NEC before clinical symptoms appear. The approach involves analyzing these samples to develop predictive models that could lead to timely interventions for affected infants. If successful, this research could provide a much-needed diagnostic tool for a condition that currently lacks predictive tests.

Why it matters

Potential benefit: If successful, this research could lead to the first predictive test for necrotizing enterocolitis, potentially reducing morbidity and mortality in premature infants.

How similar studies have gone: Other research has shown promise in using biomarkers for early detection of gastrointestinal conditions, but this specific approach is novel.

Where this research is happening

  • University of Arizona
    Tucson, United States
    Active

Researchers

  • Principal investigator: Halpern, Melissa D — University of Arizona
  • Study coordinator: Halpern, Melissa D

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.